Zhejiang, China
Prisys is a CRO company, pioneered non-human primate models covering a number of disease areas, including immunology (inflammation and autoimmunity), cardiovascula, cerebrovascula, hematology, hepatology, nephrology, pulmonology, OB-GYN, and oncology, to provide pharmacology studies of new medicines. I just started to work at Prisys as the Senior Director of R&D who is going to direct model development, as well as leading the project teams executing scientific studies for our clients on pharmacological evaluation of new drug efficacy and safety, as an important and indispensible step at pre-clinical stage to understand mechanisms of drug and provide solid guidelines for clinical trial design.
SSPC was founded on 1983 and is the largest manufacturer of clinical nutrition products (about 60% market share) in China. It is a joint-venture of Sinopharma, the largest state-owned Pharmaceutical Group, and Fresenius-Kabi, a Germany-based global health care company with special business focus on clinical nutrition. As the R&D head of SSPC, I am leading a team on developing clinical nutrition products aiming to meet the needs of Chinese market. SSPC R&D is one of three R&D sites directly led by Fresenius-Kabi global R&D center. Given fast expanding Chinese market, our team is actively working on both Parenteral nutrition and Enteral nutrition products. The scope is ranged from product concept design, formulation design, process development, scale-up, production line, to clinical trial establishment and validation.
Lead a team focusing on the Cardiovascular and Metabolic Diseases (CVMD) department. One of the unique animal model we have now is the naturally-occured type 2 diabetes monkey. This disease model that most assembles the clinical features of similar human disease attracts a lot of collaborations from big pharmas on diabetes research. I am the study director who is coordinating the projects. At the same time, I am leading a group of scientist to conduct research on Tissue and Cell Biology of diabetes related projects.
Work in an exciting area of regenerative medicine focusing on stem cell technologies and applications in diabetes, kidney, and cardiovascular diseases.